Chronic liver disease patients experience hepatic complications as a result of severe COVID-19
Louisiana team approach prevents harmful infection from spreading among vulnerable patients
15 June 2022Lager beer, whether it contains alcohol or not, could help men’s gut microbes
15 June 2022Chronic liver disease patients experience hepatic complications as a result of severe COVID-19
Patients with chronic liver disease may suffer hepatic complications as a result of severe COVID-19. A study conducted by a research team led by Lukas Hartl, Thomas Reiberger and Michael Trauner from the Division of Gastroenterology and Hepatology of MedUni Vienna and University Hospital Vienna found that a rise in cholestasis parameters and subsequent damage to the bile ducts, so-called secondary sclerosing cholangitis (SSC), develops with striking frequency in patients with pre-existing liver disease. SSC occurs significantly more frequently after COVID-19 than after other serious illnesses. The study was published in Hepatology.
